Join the club for FREE to access the whole archive and other member benefits.
Extreme personalised medicine realises there is no such thing as an average cell
Key points from article :
Single-cell sequencing can tell how individual cells in a group behave.
This technology is used by many companies to develop personalised medicine.
Highly sensitive and has the ability to detect rare cell types from limited amounts of sample material.
Single-cell collection is tricky, data analysis is complex and the sequencing procedure is very costly.
Its potential for research, drug discovery, and diagnostics is huge, but need more investments.
Click on resource name for more details.
Biotechnology company that develops life-changing medicines and discover critical biomarkers for patient care
Partner at Third Rock Ventures and Chief Scientific Officer at Celsius Therapeutics.
Research center for biophysics, cell biology and oncology and a hospital specialized in treatment of cancer
